Document is current
Any future updates will be listed below
-
Authors
Mehtonen, Juha
Teppo, Susanna
Lahnalampi, Mari
Kokko, Aleksi
Kaukonen, Riina
Oksa, Laura
Bouvy-Liivrand, Maria
Malyukova, Alena
Mäkinen, Artturi
Laukkanen, Saara
Mäkinen, Petri I.
Rounioja, Samuli
Ruusuvuori, Pekka
Sangfelt, Olle
Lund, Riikka
Lönnberg, Tapio
Lohi, Olli
Heinäniemi, Merja https://orcid.org/0000-0001-6190-3439
-
Funding
Funding for this research was provided by:
Finnish Hematology Association
Academy of Finland (321553, 321553)
Lasten Syöpäsäätiö Väreen
Emil Aaltosen Säätiö
Syöpäsäätiö
Jane ja Aatos Erkon Säätiö
Sigrid Juséliuksen Säätiö
Competitive State Research Financing of the Expert Responsibility area of Tampere University Hospital
Itä-Suomen Yliopisto
ERA PerMed
- License Information
-
More Information
Article History
Received: 7 May 2020
Accepted: 3 November 2020
First Online: 20 November 2020
Ethics approval and consent to participate
: This study was approved by the Regional Ethics Committee in Pirkanmaa, Tampere, Finland (#R13109), and conducted according to the guidelines of the Declaration of Helsinki. A written informed consent was received by the patient and/or guardians.
: A written informed consent was received by the patient and/or guardians for publication of their data. Sensitive data was stored in a controlled access database (EGA).
: The authors declare that they have no competing interests.
